Literature DB >> 7342755

Spirometric "abnormality" in a normal male reference population: further analysis of the 1971 Oregon survey.

A Miller, J C Thornton, H Smith, J F Morris.   

Abstract

Conventional criteria for spirometric impairment (FVC and FEV1 less than or equal to 79% predicted, FEF25-75 less than or equal to 74% predicted, FEV1/FVC less than or equal to 0.69 for most ages) were applied to 507 healthy nonsmoking male subjects in the 1971 Oregon survey. Frequency of air flow impairment was higher than expected for a normal population. Of all subjects, 17.8% had an "abnormal" FEF25-75% and 19.7% an "abnormal" FEV1/FVC. "Decreased" lung volumes were seen in older subjects; of those over 55 years of age, 8.8% had a reduced FVC and 11.8% a reduced FEV1. These rates in a normal population may be used as a rough baseline for making inferences about a population under study. Similar rates were found in a cross-sectional survey of nonsmoking males representative of the population of a large industrial state. The major reason for these high rates of "abnormal" spirometry lies in the conventional definitions of abnormality. Tables showing cut-off points for abnormal spirometric values based on a 95% confidence interval for adult males of all ages and heights permit an alternative method for classification as abnormal.

Mesh:

Year:  1980        PMID: 7342755     DOI: 10.1002/ajim.4700010108

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  3 in total

1.  Respiratory findings among ironworkers: results from a clinical survey in the New York metropolitan area and identification of health hazards from asbestos in place at work.

Authors:  A Fischbein; J C Luo; S Rosenfeld; M Lacher; A Miller; A Rosenbaum
Journal:  Br J Ind Med       Date:  1991-06

2.  Clinical findings among hard metal workers.

Authors:  A Fischbein; J C Luo; S J Solomon; S Horowitz; W Hailoo; A Miller
Journal:  Br J Ind Med       Date:  1992-01

Review 3.  Decline of FEV1 by age and smoking status: facts, figures, and fallacies.

Authors:  H A Kerstjens; B Rijcken; J P Schouten; D S Postma
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.